Verification of herbal treatment effect on diabetic and impaired glucose tolerance

Not Applicable

Completed

Conditions: Endocrine, nutritional and metabolic disease

Registration Number: KCT0003793

Lead Sponsor: Semyung University Oriental Medicine Hospital

Brief Summary: Evaluation of the efficacy of the treatment program through three months of herbal medicine treatment showed no significant change in blood glucose metabolism, but it was effective in improving weight - related indicators and liver function. This suggests that the Korean medicine healing program has a reduction effect on weight loss and fat hepatitis such as non - alcoholic fatty liver and alcoholic fatty liver disease. As a result of evaluating the safety of taking herbal medicines, there was no serious adverse reaction requiring moderate side effects or treatment during the period of use, and herbal medicine could be safely used because blood pressure and hematological test did not show abnormal findings.

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 56

Inclusion Criteria

1. Those who are between 20 and 80 years of age
2. Diabetic patients taking or administering an oral hypoglycemic agent or insulin
OR Those with a fasting blood glucose level of 110 mg / dL or more
OR those with a blood glucose level of 140 mg / dL or more for 2 hours after a meal
3. A person who voluntarily signs a clinical study agreement
4. Those who are willing to cooperate during the study period and who will comply with the restrictions

Exclusion Criteria

1. Subjects with a history of drug hypersensitivity to medicines and food ingredients
2. Subjects who have severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.), heart disease (angina pectoris, myocardial infarction, heart failure, arrhythmia requiring treatment), pulmonary disease (chronic obstructive pulmonary disease, etc.) within the last 6 months
(However, patients who have a history of cerebrovascular disease or heart disease but are clinically stable can participate in the test by the judgment of the tester.)
3. Severe dysfunction of liver and kidney (ALT, AST = 2.5 times the upper limit of normal) (Creatinine> 2.0 mg / dl)
4. Diagnosis of malignancy within 3 years before screening
5. In the opinion of the person in charge of testing applied to the human body, the person who is judged to be unable to comply with the test
6. People with mental illness who are difficult to communicate
7. Subject of pregnancy